Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for ...

Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.

Milvexian is in three late-stage studies in AF, stroke, and acute coronary syndromes (ACS), while abelacimab is in the phase 3 LILAC-TIMI 76 in patients with AF deemed unsuitable for current OAC ...

John Friend, MD, CEO of Kazia Therapeutics added, "The novelty of the science that Professor Rao has proposed with this dual ...

The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the ...

Blackstone (NYSE: BX), the world’s largest alternative asset manager, is expanding its presence in the life sciences sector with a new multibillion-dollar fund dedicated to drug development. The firm ...

BELGRADE - Serbia's top-ranked tennis player Novak Djokovic says he is thinking about retirement, "about more how than when." "I feel if I start to lose more and feel like there is a bigger gap, that ...

BELGRADE - Following a decision by President Aleksandar Vucic to pardon 13 people detained during protest blockades in the country, the Public Prosecutor's Office of Serbia will halt criminal ...